An application of weighted support vector machines to individualized second-line therapy selection after levodopa in Parkinson's disease.

Authors

Cuong T Pham, Ruth B Schneider, Charles S Venuto, Greta Smith, Zachary P Brehm, Michael P McDermott, Ashkan Ertefaie

Published in

Frontiers in human neuroscience. Volume 20. Pages 1859515. Epub Jul 10, 2026.

Abstract

Parkinson's disease (PD) is a progressive neurological disorder characterized by motor symptoms, with treatment responses varying widely across patients. To address the growing need for individualized treatment strategies, this paper introduces a practical framework for constructing optimal individualized treatment strategies using weighted support vector machines (SVMs). We construct an optimal rule as a function of patients' clinical profiles and demographics using two methods: Outcome-Weighted Learning (OWL), which assumes no unmeasured confounders, and Instrumental Variable Outcome-Weighted Learning (IV-OWL), which accounts for potential unmeasured confounders. To illustrate the application of these methods, we use harmonized and curated clinical data from the NET-PD LS1 and PRECEPT/POSTCEPT studies to estimate the optimal second-line therapy decision rule for supplementing levodopa with either monoamine oxidase B (MAO-B) inhibitors or dopamine receptor agonists (DRA) based on patient characteristics. As an illustrative application, we analyzed two cohorts of patients who initiated second-line therapy within 90 and 180 days of baseline, with sample sizes of 84 and 121, respectively. Although the estimated improvements were not statistically significant, likely due in part to the small sample sizes, the learned IV-OWL rule showed improvement in annualized UPDRS III change compared with the observed treatment strategy and other static treatment strategies. This case study demonstrates the feasibility of applying weighted support vector machines to individualized second-line therapy selection in PD and illustrates the potential value of instrumental variable-based methods in addressing unmeasured confounders.

PMID:
42499378
Bibliographic data and abstract were imported from PubMed on 25 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.